On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...

A doctor has issued a health warning to people who are on three common types of medication via an NHS repeat prescription.

A doctor has issued a health warning to people who are on three common types of medication via an NHS repeat prescription.

Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat ...

Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial ...

With lung conditions the third biggest killer in Northern Ireland, Asthma + Lung UK Northern Ireland is calling for better ...

Major advancements in pulmonary fibrosis treatment and critical warnings regarding both indoor air quality and scientific ...